Altavo just raised. Here's exactly what to do next.
Who to reach, what to say, and why now — on Altavo, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Everyone else gives you a piece
Only Fundz delivers all four.
Altavo, a medtech startup, raised €3M in Series A2 funding led by Novalis Biotech to develop its AI-based voice rehabilitation products.
Amount Raised
€3 Million
Round Type
SERIES A
Investors
Description
Altavo, based in Dresden, Germany, specializes in AI-based voice rehabilitation and has successfully raised €3M in a Series A2 financing round. The round was led by Novalis Biotech and other notable investors. The funds will be used for company development and clinical work for its commercial product. Founded in 2021, Altavo is positioned to innovate in the medical device space.
Related People
Funding Insights
Based on industry dataWatching Altavo? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan